JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3626
FerroAtlántica
GSM
$811M
| $1.13M | ﹤0.01% |
691,362
-27,255
| -4% | -$51.9K |
2016 Q4
10 quarters
|
|
|
CUB
3627
DELISTED
Cubic Corporation
CUB
| $1.13M | ﹤0.01% |
17,963
-4,719
| -21% | -$277K |
2014 Q4
18 quarters
|
|
3628
CALL
Euronet Worldwide
EEFT
$2.38B
| $1.13M | ﹤0.01% |
+6,900
| New | +$1.05M |
2019 Q2
0 quarters
|
|
|
3629
PUT
Euronet Worldwide
EEFT
$2.38B
| $1.13M | ﹤0.01% |
+6,900
| New | +$1.05M |
2019 Q2
0 quarters
|
|
3630
Perdoceo Education
PRDO
$2.01B
| $1.13M | ﹤0.01% |
59,983
+21,797
| +57% | +$402K |
2015 Q4
14 quarters
|
|
|
ESV
3631
DELISTED
Ensco Rowan plc
ESV
| $1.13M | ﹤0.01% |
134,650
+55,023
| +69% | +$636K |
2013 Q2
24 quarters
|
|
|
ACRE
3632
Ares Commercial Real Estate
ACRE
$208M
| $1.13M | ﹤0.01% |
76,866
-15,691
| -17% | -$237K |
2015 Q3
15 quarters
|
|
3633
Allient
ALNT
$1.99B
| $1.13M | ﹤0.01% |
44,931
+3,883
| +9% | +$93K |
2017 Q4
6 quarters
|
|
3634
Camtek
CAMT
$7.21B
| $1.13M | ﹤0.01% |
133,405
+29,968
| +29% | +$276K |
2018 Q2
4 quarters
|
|
3635
Federal Agricultural Mortgage
AGM
$2.32B
| $1.12M | ﹤0.01% |
15,668
+11,781
| +303% | +$867K |
2016 Q1
13 quarters
|
|
|
WPG
3636
DELISTED
Washington Prime Group Inc.
WPG
| $1.12M | ﹤0.01% |
33,465
-96,643
| -74% | -$3.97M |
2014 Q2
20 quarters
|
|
3637
Emergent Biosolutions
EBS
$356M
| $1.12M | ﹤0.01% |
23,338
+1,272
| +6% | +$61K |
2014 Q1
21 quarters
|
|
3638
Ultragenyx Pharmaceutical
RARE
$1.43B
| $1.12M | ﹤0.01% |
18,049
-1,227
| -6% | -$78.1K |
2014 Q1
21 quarters
|
|
3639
Citi Trends
CTRN
$410M
| $1.12M | ﹤0.01% |
75,968
+3,070
| +4% | +$52.5K |
2016 Q2
12 quarters
|
|
3640
BlackRock MuniYield Quality Fund
MQY
$1.5B
| $1.12M | ﹤0.01% |
77,056
-101,033
| -57% | -$1.44M |
2019 Q1
1 quarter
|
|
3641
UNIFI
UFI
$122M
| $1.11M | ﹤0.01% |
62,918
+25,188
| +67% | +$487K |
2013 Q2
24 quarters
|
|
3642
CALL
Western Digital
WDC
$148B
| $1.11M | ﹤0.01% |
+33,075
| New | +$1.13M |
2019 Q2
0 quarters
|
|
|
ADAP
3643
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.11M | ﹤0.01% |
278,120
-124,234
| -31% | -$507K |
2016 Q3
11 quarters
|
|
3644
Wave Life Sciences
WVE
$694M
| $1.11M | ﹤0.01% |
42,239
-86,627
| -67% | -$2.43M |
2017 Q3
7 quarters
|
|
3645
iShares MSCI Malaysia ETF
EWM
$285M
| $1.11M | ﹤0.01% |
37,138
-478,232
| -93% | -$14M |
2013 Q2
24 quarters
|
|
|
JKS
3646
JinkoSolar
JKS
$476M
| $1.11M | ﹤0.01% |
49,679
-67,371
| -58% | -$1.36M |
2019 Q1
1 quarter
|
|
|
SCWX
3647
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $1.11M | ﹤0.01% |
82,910
+49,410
| +147% | +$821K |
2016 Q3
11 quarters
|
|
3648
Flotek Industries
FTK
$1.09B
| $1.1M | ﹤0.01% |
57,696
+23,803
| +70% | +$483K |
2015 Q4
14 quarters
|
|
3649
Protolabs
PRLB
$2.33B
| $1.1M | ﹤0.01% |
9,845
+1,359
| +16% | +$146K |
2016 Q2
12 quarters
|
|
|
BXG
3650
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
| $1.1M | ﹤0.01% |
94,206
+92,275
| +4,779% | +$1.18M |
2018 Q3
3 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.